Atelvia

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0430-0979
  • Package NDC 0430-0979-03
  • Application number NDA022560
  • SPL ID 936662af-4e07-4361-b7ef-760ebfad3e01
  • SPL set ID c8b9ab88-1a26-46c3-80ec-4eaa45202021
  • UNII HU2YAQ274O
  • UNII F67L43UT5C
  • RxCUI 1020064
  • RxCUI 1020065
  • RxCUI 1020066

What the source publishes

Labeler
Allergan, Inc.
Active ingredients
risedronate sodium
Form
TABLET, DELAYED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0430-0979_936662af-4e07-4361-b7ef-760ebfad3e01
{
  "name": "Atelvia",
  "splId": "936662af-4e07-4361-b7ef-760ebfad3e01",
  "labels": [
    {
      "setId": "c8b9ab88-1a26-46c3-80ec-4eaa45202021",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8b9ab88-1a26-46c3-80ec-4eaa45202021",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c8b9ab88-1a26-46c3-80ec-4eaa45202021"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Allergan, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "4 TABLET, DELAYED RELEASE in 1 DOSE PACK (0430-0979-03)",
      "package_ndc": "0430-0979-03",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20101201"
    }
  ],
  "productId": "0430-0979_936662af-4e07-4361-b7ef-760ebfad3e01",
  "useDomain": "unknown",
  "dosageForm": "TABLET, DELAYED RELEASE",
  "productNdc": "0430-0979",
  "deaSchedule": null,
  "genericName": "risedronate sodium",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "RISEDRONATE SODIUM HEMIPENTAHYDRATE",
      "strength": "30.1 mg/1"
    },
    {
      "name": "RISEDRONATE SODIUM MONOHYDRATE",
      "strength": "4.9 mg/1"
    }
  ],
  "applicationNumber": "NDA022560",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20101201",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "HU2YAQ274O",
      "F67L43UT5C"
    ],
    "rxcui": [
      "1020064",
      "1020065",
      "1020066"
    ],
    "spl_set_id": [
      "c8b9ab88-1a26-46c3-80ec-4eaa45202021"
    ],
    "manufacturer_name": [
      "Allergan, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0430-0979_936662af-4e07-4361-b7ef-760ebfad3e01"